Machine Learning at GSK with Kim Branson - #536

The TWIML AI Podcast (formerly This Week in Machine Learning & Artificial Intelligence)

Вміст надано TWIML and Sam Charrington. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією TWIML and Sam Charrington або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.

2+ y ago 1:00:36

MP3•Головна епізоду

Today we’re joined by Kim Branson, the SVP and global head of artificial intelligence and machine learning at GSK.

We cover a lot of ground in our conversation, starting with a breakdown of GSK’s core pharmaceutical business, and how ML/AI fits into that equation, use cases that appear using genetics data as a data source, including sequential learning for drug discovery. We also explore the 500 billion node knowledge graph Kim’s team built to mine scientific literature, and their “AI Hub”, the ML/AI infrastructure team that handles all tooling and engineering problems within their organization. Finally, we explore their recent cancer research collaboration with King’s College, which is tasked with understanding the individualized needs of high- and low-risk cancer patients using ML/AI amongst other technologies.

The complete show notes for this episode can be found at twimlai.com/go/536.

699 епізодів

#Artificial Intelligence #Tech News #Artificialintelligence #Machinelearning #Samcharrington #Technology #Thisweekinmachinelearning #Sam Charrington #Thetwimlaipocast #Twimlaipodcast #Tech #News #China #TWIML #Datascience #Science